Table 2 Therapy failure-related adaptive mutations.

From: Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy

Mutationa

bnAbs

Population frequency

Regiona

TF group

VS group

TF group

VS group

Ka/Ks

Sequence frequency

Ka/Ks

Sequence frequency

K59R

0.15

0.04

C1

24

0.08

0.75

0.04

V84I

0.2

0.04

C1

30.95

0.06

0.25

0

I108V

0.2

0.08

C1

17.27

0.08

2.18

0.01

L134Y

PGT122

0.2

0.04

V1-V2

7.2

0.13

0.82

0.03

K135L

0.15

0.04

V1-V2

7.67

0.08

0.35

0.03

D137L

0.15

0

V1-V2

27

0.09

T138R

0.15

0

V1-V2

21

0.07

G145N

0.5

0.08

V1-V2

58

0.2

0.67

0.01

M149S

0.15

0

V1-V2

4

0.01

E150S

0.15

0

V1-V2

40

0.14

R166Q

PG9, PG16

0.15

0

V1-V2

25

0.09

Q170K

0.15

0

V1-V2

72.26

0.09

L179I

830A

0.15

0

V1-V2

138.6

0.1

P183K

0.15

0

V1-V2

30

0.1

T194M

0.2

0.04

V1-V2

7

0.02

2

0.01

T232K

35O22

0.3

0.16

C2

3.87

0.18

0.97

0.08

T232R

0.15

0

C2

2.43

0.11

T240K

0.15

0.04

C2

71.69

0.1

2.38

0

V242I

0.15

0.04

C2

1.99

0.08

0.04

0

E267K

0.15

0.04

C2

1.7

0.06

0.5

0

E269G

0.25

0.12

C2

2.27

0.09

0.69

0.05

V292I

B12

0.25

0.08

C2

2.46

0.04

1.04

0.01

E293T

0.15

0.04

C2

23

0.08

0.5

0

E293I

0.2

0.04

C2

7

0.02

0.5

0

N295D

0.3

0.04

C2

3.5

0.07

0.33

0

I371V

VRC01

0.55

0.04

C3

27.65

0.21

1.36

0

N392S

PGT135

0.2

0.04

V4

1.18

0.14

0.03

0

F396H

0.15

0

V4

14

0.05

N397T

0.2

0

V4

63.93

0.08

T402N

0.2

0.04

V4

47.79

0.04

14.27

0.01

S405Q

0.15

0.04

V4

1.18

0.05

0.1

0.01

N407G

0.5

0.28

V4

1.57

0.25

0.98

0.14

R419K

B12

0.3

0.08

C4

1.14

0.13

0.55

0.03

A607N

0.15

0

gp41

46

0.16

E662K

2F5

0.35

0

gp41

61

0.21

N677K

4E10

0.8

0.44

gp41

3.33

0.61

0.94

0.27

  1. aHXB2 Env was used as a reference sequence.—: no associated bnAbs.